Shareholders' Investment

6 Months Ended

Jun. 30, 2017

11. Shareholders’ Investment

The company repurchased approximately 1.0 million shares of common stock for $232.3 million in the six months ended June 30, 2017 under its previously announced share repurchase authorization.

Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive income (loss) by component are as follows:


	Derivative Instruments Designated as Cash Flow Hedges			Foreign Currency Translation Adjustments			Benefit Plans			Total
(dollars in millions)
Balance at December 31, 2015	$	(8.7	)	$	(94.2	)	$	(105.1	)	$	(208.0	)
Other comprehensive income (loss) before reclassifications		(28.9	)		20.7			—			(8.2	)
Tax (provision) benefit ^(a)		8.6			—			—			8.6

Other comprehensive income (loss) before reclassifications, net of taxes		(20.3	)		20.7			—			0.4

Reclassifications		4.1	^(b)		—			5.2	^(c)		9.3
Tax provision (benefit)		0.7			—			(1.8	)		(1.1	)

Reclassifications, net of tax		4.8			—			3.4			8.2

Other comprehensive income (loss)		(15.5	)		20.7			3.4			8.6

Balance at June 30, 2016	$	(24.2	)	$	(73.5	)	$	(101.7	)	$	(199.4	)


Balance at December 31, 2016	$	(9.9	)	$	(116.0	)	$	(109.6	)	$	(235.5	)
Other comprehensive income (loss) before reclassifications		1.0			28.7			—			29.7
Tax (provision) benefit ^(a)		1.8			—			—			1.8

Other comprehensive income (loss) before reclassifications, net of taxes		2.8			28.7			—			31.5

Reclassifications		4.9	^(b)		—			6.5	^(c)		11.4
Tax provision (benefit)		(0.3	)		—			(2.2	)		(2.5	)

Reclassifications, net of tax		4.6			—			4.3			8.9

Other comprehensive income (loss)		7.4			28.7			4.3			40.4

Balance at June 30, 2017	$	(2.5	)	$	(87.3	)	$	(105.3	)	$	(195.1	)

(a)	Income taxes are not provided for foreign currency translation adjustment.

(b)	See Note 6 of the notes to condensed consolidated financial statements.

(c)	These components are included in the computation of net periodic pension cost. See Note 10 of the notes to condensed consolidated financial statements.

BARD C R INC /NJ/ 10-Q